Older women suffering from clinical frailty stand to benefit from the first potential medical treatment for the condition, according to a new study. Ghrelin, a hormone that stimulates appetite, was administered to older women diagnosed with frailty, a common geriatric syndrome characterized by unintentional weight loss, weakness, exhaustion and low levels of anabolic hormones which increases risk of falls, hospitalizations, disability and death.